What is the clinical evidence from this study?

Study design: Observational. Population: Familial hypercholesterolemia. Intervention: Tracer kinetic methodology vs. Normal and hypertriglyceridemic subjects. Primary outcome: ApoB metabolism and LDL production.

What does this research mean for the field?

In patients with heterozygous familial hypercholesterolemia, total apoB secretion is reduced, but nearly 40% is secreted as IDL/LDL and fully converted to LDL, resulting in increased total LDL production. Novelty: ClaimNovelty.CONTRADICTORY. Consensus alignment: ConsensusAlignment.CHALLENGES_CONSENSUS.

What question did this study set out to answer?

To evaluate in vivo hepatic apolipoprotein B metabolism in patients with heterozygous familial hypercholesterolemia and assess discrepancies with the classical in vitro low-density lipoprotein receptor paradigm.

April 1, 1994Arteriosclerosis and Thrombosis A Journal of Vascular Biology

ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.

View Full Paper

Ask AI

Bookmark

Key result

In patients with heterozygous familial hypercholesterolemia, total apoB secretion is reduced but almost 40% is secreted as IDL/LDL and fully converted to LDL, increasing total LDL production.

Why the study?

How does apoB metabolism in patients with heterozygous familial hypercholesterolemia differ from normal and hypertriglyceridemic subjects?

Key Points

To evaluate in vivo hepatic apolipoprotein B metabolism in patients with heterozygous familial hypercholesterolemia and assess discrepancies with the classical in vitro low-density lipoprotein receptor paradigm.
Assessed in vivo apolipoprotein B kinetics using tracer kinetic methodology.
Compared patients with heterozygous familial hypercholesterolemia to normal and hypertriglyceridemic control subjects.
Patients with heterozygous familial hypercholesterolemia showed reduced total apolipoprotein B production but secreted nearly 40% of apolipoprotein B as intermediate-density or low-density lipoprotein, compared to control subjects who primarily secreted large very-low-density lipoprotein.
All secreted apolipoprotein B was converted to low-density lipoprotein in familial hypercholesterolemia patients, whereas approximately 50% was catabolized prior to conversion in normal controls and roughly two-thirds was catabolized in hypertriglyceridemic controls.
Elevated circulating low-density lipoprotein resulted from the combination of increased total low-density lipoprotein production and impaired receptor-mediated clearance.

Study Design

Type

Observational

Structured PICO

How does apoB metabolism in patients with heterozygous familial hypercholesterolemia differ from normal and hypertriglyceridemic subjects?

Population

Patients with heterozygous familial hypercholesterolemia (FH), with normal and hypertriglyceridemic (HTG) subjects as controls

Intervention

Tracer kinetic methodology to assess apoB metabolism

Comparator

Normal and hypertriglyceridemic (HTG) subjects

Outcome

ApoB production, secretion pathways, and catabolismsurrogate

The elevated LDL in heterozygous FH is driven by both decreased LDL receptor-mediated catabolism and increased LDL production due to full conversion of secreted apoB to LDL.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Indicates dual LDL drivers in heterozygous FH; challenges receptor-only paradigm but hypothesis-generating from cross-sectional data.

Cite This Study

Fisher et al. (1994) conducted an observational in Familial hypercholesterolemia. Tracer kinetic methodology vs. Normal and hypertriglyceridemic subjects was evaluated on ApoB metabolism and LDL production. In patients with heterozygous familial hypercholesterolemia, total apoB secretion is reduced but almost 40% is secreted as IDL/LDL and fully converted to LDL, increasing total LDL production.

synapsesocial.com/papers/6a1258c3c031bb6829a6606b https://doi.org/10.1161/01.atv.14.4.501

View Full Paper

Ask AI

Bookmark

ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.

Key Points

Study Design

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider